Balyasny Asset Management’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
34,912
-46,171
| -57% | -$158K | ﹤0.01% | 1878 |
|
|
2025
Q1 | $181K | Buy |
81,083
+67,562
| +500% | +$151K | ﹤0.01% | 1833 |
|
|
2024
Q4 | $39.6K | Buy |
+13,521
| New | +$39.6K | ﹤0.01% | 1849 |
|
|
2024
Q3 | – | Sell |
-34,794
| Closed | -$103K | – | 1904 |
|
|
2024
Q2 | $103K | Sell |
34,794
-23,716
| -41% | -$70.2K | ﹤0.01% | 1764 |
|
|
2024
Q1 | $265K | Buy |
58,510
+43,657
| +294% | +$198K | ﹤0.01% | 1696 |
|
|
2023
Q4 | $84.8K | Buy |
+14,853
| New | +$84.8K | ﹤0.01% | 1821 |
|
|
2023
Q3 | – | Sell |
-1,134,269
| Closed | -$7.33M | – | 1718 |
|
|
2023
Q2 | $7.33M | Buy |
+1,134,269
| New | +$7.33M | 0.02% | 683 |
|
|
2023
Q1 | – | Sell |
-153,025
| Closed | -$1.55M | – | 2136 |
|
|
2022
Q4 | $1.55M | Buy |
153,025
+102,193
| +201% | +$1.04M | ﹤0.01% | 1135 |
|
|
2022
Q3 | $503K | Buy |
+50,832
| New | +$503K | ﹤0.01% | 1577 |
|
|
2022
Q2 | – | Sell |
-62,339
| Closed | -$608K | – | 2241 |
|
|
2022
Q1 | $608K | Buy |
+62,339
| New | +$608K | ﹤0.01% | 1443 |
|